Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  28 (2024)
Volume  27 (2023)
Volume  26 (2022)
Volume  25 (2021)
Volume  24 (2020)
Volume  23 (2019)
Volume  22 (2018)
Volume  21 (2017)
Volume  20 (2016)
Volume  19 (2015)
Volume  18 (2014)
Volume  17 (2013)
Volume  16 (2012)
Volume  15 (2011)
Volume  14 (2010)
Volume  13 (2009)
Volume  12 (2008)
Volume  11 (2007)
Volume  10 (2006)
Volume  9 (2005)
Volume  8 (2004)
Related articles

VOLUME 24 , ISSUE 4 ( April, 2020 ) > List of Articles

Original Article

An Observational Study of QTc Prolongation in Critically Ill Patients: Identification of Incidence and Predictors

Shadi Baniasadi, Seyyed R Seyyedi, Mehdi Rajabi

Keywords : Critically ill patient, Intensive care unit, QTc prolongation

Citation Information : Baniasadi S, Seyyedi SR, Rajabi M. An Observational Study of QTc Prolongation in Critically Ill Patients: Identification of Incidence and Predictors. Indian J Crit Care Med 2020; 24 (4):270-275.

DOI: 10.5005/jp-journals-10071-23411

License: CC BY-NC 4.0

Published Online: 01-08-2019

Copyright Statement:  Copyright © 2020; The Author(s).


Abstract

Aims: Despite the importance of abnormal QTc interval values in intensive care unit (ICU) patients, there is a paucity of information on this topic. The current study was designed to identify the incidence and predictors of QTc prolongation in medical (M), surgical (S), and emergency (E) ICUs. Materials and methods: A prospective observational study was conducted for 6 months. Patients more than 18 years old who admitted to MICU, SICU, and EICU were included in the study. Electrocardiogram (ECG) was taken on day 1, 3, and 5 of ICU admission. The QTc intervals >460 ms in male and >470 ms in female and increased >60 ms above baseline were considered QTc prolongation. Comparative analysis was done between two groups of patients (normal vs prolonged QTc). Logistic regression models were carried out to determine the predictors of QTc prolongation. Results: Incidence of QTc prolongation was 6.5, 9.8, and 15.7% on day 1, 3, and 5 of ICU admission, respectively. On day 1, the history of alcohol addiction and the reason of ICU admission were associated with a prolonged QTc. A significant association was demonstrated between administration of azithromycin and QTc prolongation on day 3. High serum creatinine and hospitalization in EICU were predictors of QTc prolongation on day 5 of ICU admission. Conclusion: The QTc prolongation is relatively common among patients admitted to ICUs and its incidence increases with increasing length of hospital stay. Predictors of QTc prolongation may be affected by the duration of ICU admission. Physicians should consider these predictors particularly before prescribing QTc-prolonging drugs.

HTML PDF Share
  1. World Health Organization, News room. Available from: https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)/. Accessed May 17, 2017.
  2. Reinelt P, Karth G, Geppert A, Heinz G. Incidence and type of cardiac arrhythmias in critically ill patients: a single center experience in a medical-cardiological ICU. Intensive Care Med 2001;27(9):1466–1473. DOI: 10.1007/s001340101043.
  3. Armahizer MJ, Seybert AL, Smithburger PL, Kane-Gill SL. Drug-drug interactions contributing to QT prolongation in cardiac intensive care units. J Crit Care 2013;28(3):243–249. DOI: 10.1016/j.jcrc.2012. 10.014.
  4. Crouch MA, Limon L, Cassano AT. Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy 2003;23(7):881–908. DOI: 10.1592/phco.23.7.881.32730.
  5. Nelson S, Leung J. QTc prolongation in the intensive care unit. AACN Adv Crit Care 2011;22(4):289–295. DOI: 10.4037/NCI.0b013e31822db49d.
  6. Kallergis EM, Goudis CA, Simantirakis EN, Kochiadakis GE, Vardas PE. Mechanisms, risk factors, and management of acquired long QT syndrome: a comprehensive review. Sci World J. 2012;2012:1–8. DOI: 10.1100/2012/212178.
  7. Ng TMH, Olsen KM, McCartan MA, Puumala SE, Speidel KM, Miller MA, et al. Drug-induced QTc-interval prolongation in the intensive care unit: incidence and predictors. J Pharm Pract 2010;23(1):19–24. DOI: 10.1177/0897190009356549.
  8. Lam YWF. Drugs and QT interval prolongation in patients with PTSD. The Brown University Psychopharmacol 2019;30(2):2–3. DOI: 10.1002/pu.30391.
  9. Vincenzi FF. Fatal drowning associated with QT prolongation caused by alcohol, some drugs, and congenital long QT syndrome: the role of the diving reflex. EC. Pharmacol Toxicol 2018;6(7):622–633.
  10. Gowda RM, Khan IA, Wilbur SL, Vasavada BC, Sacchi TJ. Torsade de pointes: the clinical considerations. Int J Cardio 2004;96(1):1–6. DOI: 10.1016/j.ijcard.2003.04.055.
  11. Zhang Y, Ouyang P, Post WS, Dalal D, Vaidya D, Blasco-Colmenares E, et al. Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third national health and nutrition examination survey and the multi-ethnic study of atherosclerosis. Am J Epidemiol 2011;174(4):403–411. DOI: 10.1093/aje/kwr172.
  12. Carnethon MR, Anthony MS, Cascio WE, Folsom AR, Rautaharju PM, Liao D, et al. A prospective evaluation of the risk of QT prolongation with hormone replacement therapy: the atherosclerosis risk in communities study. Ann Epidemiol 2003;13(7):530–536. DOI: 10.1016/s1047-2797(03)00050-4.
  13. Charbit B, Christin-Maître S, Démolis J-L, Soustre E, Young J, Funck-Brentano C. Effects of testosterone on ventricular repolarization in hypogonadic men. Am J Cardiol 2009;103(6):887–890. DOI: 10.1016/j.amjcard.2008.11.041.
  14. Ma T, Cai J, Zhu Y-S, Chu X-F, Wang Y, Shi G-P, et al. Association between a frailty index based on common laboratory tests and QTc prolongation in older adults: the rugao longevity and ageing study. Clin Interv Aging 2018;13:797–804. DOI: 10.2147/CIA.S149791.
  15. Pickham D, Flowers E, Drew BJ. Hyperglycemia is associated with corrected QT prolongation and mortality in acutely ill patients. J Cardio Nurs 2014;29(3):264. DOI: 10.1097/JCN.0b013e31827f174c.
  16. Hegyi B, Borst JM, Lucena AJ, Bailey LRJ, Bossuyt J, Bers DM. Diabetic hyperglycemia regulates potassium channels and arrhythmias in the heart via autonomous CaMKII activation by O-linked glycosylation. Biophys J 2019;116(3):98a. DOI: 10.1016/j.bpj.2018.11.566.
  17. Fernandes FM, Silva EP, Martins RR, Oliveira AG. QTc interval prolongation in critically ill patients: prevalence, risk factors and associated medications. PLoS ONE 2018;13(6):e0199028. DOI: 10.1371/journal.pone.0199028.
  18. Beitland S, Platou ES, Sunde K. Drug-induced long QT syndrome and fatal arrhythmias in the intensive care unit. Acta Anaesthesiol Scandinavica 2014;58(3):266–272. DOI: 10.1111/aas.12257.
  19. Tisdale JE, Wroblewski HA, Overholser BR, Kingery JR, Trujillo TN, Kovacs RJ. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs. Drug Safe 2012;35(6):459–470. DOI: 10.2165/11598160-000000000-00000.
  20. Smithburger PL, Seybert AL, Armahizer MJ, Kane-Gill SL. QT prolongation in the intensive care unit: commonly used medications and the impact of drug–drug interactions. Expert Opin Drug Safe 2010;9(5):699–712. DOI: 10.1517/14740331003739188.
  21. Zarowitz BJ, Tisdale JE. Navigating the minefield of QTc interval-prolonging therapy in nursing facility residents. J Am Geriatr Soci 2019;67(7):1–8. DOI: 10.1111/jgs.15810.
  22. Indik JH, Pearson EC, Fried K, Woosley RL. Bazett and fridericia QT correction formulas interfere with measurement of drug-induced changes in QT interval. Heart Rhythm 2006;3(9):1003–1007. DOI: 10.1016/j.hrthm.2006.05.023.
  23. Luo S, Michler K, Johnston P, Macfarlane PW. A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. J Electrocardiol 2004;37(Suppl. 1):81–90. DOI: 10.1016/j.jelectrocard.2004.08.030.
  24. Manini AF, Stimmel B, Vlahov D. Racial susceptibility for QT prolongation in acute drug overdoses. J Electrocardiol 2014;47(2): 244–250. DOI: 10.1016/j.jelectrocard.2013.12.002.
  25. International Statistical Classification of Diseases and Related Health Problems 10th Revisione. WHO. Available from: https://icd.who.int/browse10/2016/en/. Accessed April 17, 2018.
  26. Incredible Medicine. Available from: https://crediblemeds.org/. Accessed March 18, 2018.
  27. Khode VH, Kammar KF. QTc changes in non-pregnant females with severe iron deficiency anaemia. J Clin Diagnostic Res 2012;6(5): 777–779.
  28. Hematocrit test. Mayoclinic. Available from: https://www.mayoclinic.org/tests-procedures/hematocrit/about/pac-20384728. Accessed February 8, 2019.
  29. Klimas J, Stankovicova T, Kyselovic J, Bacharova L. Prolonged QT interval is associated with blood pressure rather than left ventricular mass in spontaneously hypertensive rats. Clin Exp Hypertens 2008;30(7):475–485. DOI: 10.1080/10641960802443399.
  30. Haarmark C, Hansen PR, Vedel-Larsen E, Haahr Pedersen S, Graff C, Andersen MP, et al. The prognostic value of the Tpeak-Tend interval in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. J Electrocardiol 2009;42(6):555–560. DOI: 10.1016/j.jelectrocard.2009.06.009.
  31. Pierard LA, Carabello BA. Ischaemic mitral regurgitation: pathophysiology, outcomes and the conundrum of treatment. Eur Heart J 2010;31(24):2996–3005. DOI: 10.1093/eurheartj/ehq411.
  32. Russo V, Puzio G, Siniscalchi N. Azithromycin-induced QT prolongation in elderly patient. Acta Bio Medica Atenei Parmensis 2006;77(1):30–32.
  33. Huang B-H, Wu C-H, Hsia C-P, Yin Chen C. Azithromycin-induced torsade de pointes. Pacing Clin Electrophysiol 2007;30(12):1579–1582. DOI: 10.1111/j.1540-8159.2007.00912.x.
  34. Administration USF and D. FDA drug safety communication: Azithromycin (Zithromax or Zmax) and the risk of potentially fatal heart rhythms. Drug Safety Communications. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-azithromycin-zithromax-or-zmax-and-risk-potentially-fatal-heart. Accessed March 18, 2019.
  35. Rao GA, Mann JR, Shoaibi A, Bennett CL, Nahhas G, Sutton SS, et al. Azithromycin and levofloxacin use and increased risk of cardiac arrhythmia and death. Ann Fam Med 2014;12(2):121–127. DOI: 10.1370/afm.1601.
  36. Guidelines TOSUWMC clinical practice. QT prolongation guidelines. Available from: https://evidencebasedpractice.osumc.edu/Documents/Guidelines/QTc%0AProlongationandTdP.Pdf. Accessed March 14, 2018.
  37. Kim SM, George B, Alcivar-Franco D, Campbell CL, Charnigo R, Delisle B, et al. QT prolongation is associated with increased mortality in end stage liver disease. World J Cardiol 2017;9(4):347. DOI: 10.4330/wjc.v9.i4.347.
  38. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, et al. Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 2009;75(6):652–660. DOI: 10.1038/ki.2008.638.
  39. Kumar S, Birda C, Bhalla A, Sharma N, Kumari S. Prevalence and prognostic significance of prolonged QTc interval in emergency medical patients: a prospective observational study. Int J Crit Illn Inj Sci 2018;8(1):28. DOI: 10.4103/IJCIIS.IJCIIS_59_17.
  40. Pourmand A, Mazer-Amirshahi M, Chistov S, Sabha Y, Vukomanovic D, Almulhim M. Emergency department approach to QTc prolongation. am. J Emerg 2017;35(12):1928–1933. DOI: 10.1016/j.ajem.2017.08.044.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.